JP2021531259A5 - - Google Patents
Info
- Publication number
- JP2021531259A5 JP2021531259A5 JP2021500508A JP2021500508A JP2021531259A5 JP 2021531259 A5 JP2021531259 A5 JP 2021531259A5 JP 2021500508 A JP2021500508 A JP 2021500508A JP 2021500508 A JP2021500508 A JP 2021500508A JP 2021531259 A5 JP2021531259 A5 JP 2021531259A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- disorder
- syndrome
- traumatic brain
- brain injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024116690A JP2024156720A (ja) | 2018-03-23 | 2024-07-22 | Ｇタンパク質共役受容体の調節剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862647604P | 2018-03-23 | 2018-03-23 | |
| US62/647,604 | 2018-03-23 | ||
| PCT/US2019/023726 WO2019183577A1 (en) | 2018-03-23 | 2019-03-22 | Modulators of g-protein coupled receptors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024116690A Division JP2024156720A (ja) | 2018-03-23 | 2024-07-22 | Ｇタンパク質共役受容体の調節剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021531259A JP2021531259A (ja) | 2021-11-18 |
| JP2021531259A5 true JP2021531259A5 (https=) | 2024-05-13 |
| JP7526716B2 JP7526716B2 (ja) | 2024-08-01 |
Family
ID=67986596
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500508A Active JP7526716B2 (ja) | 2018-03-23 | 2019-03-22 | Ｇタンパク質共役受容体の調節剤 |
| JP2024116690A Pending JP2024156720A (ja) | 2018-03-23 | 2024-07-22 | Ｇタンパク質共役受容体の調節剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024116690A Pending JP2024156720A (ja) | 2018-03-23 | 2024-07-22 | Ｇタンパク質共役受容体の調節剤 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11535660B1 (https=) |
| EP (1) | EP3768294A4 (https=) |
| JP (2) | JP7526716B2 (https=) |
| CN (1) | CN112236161A (https=) |
| AR (1) | AR115016A1 (https=) |
| AU (2) | AU2019237507B2 (https=) |
| BR (1) | BR112020019148A2 (https=) |
| CA (1) | CA3094820A1 (https=) |
| EA (1) | EA202092269A1 (https=) |
| IL (3) | IL311177B2 (https=) |
| MX (2) | MX2020009950A (https=) |
| MY (1) | MY205468A (https=) |
| PH (1) | PH12020551539A1 (https=) |
| SG (1) | SG11202009338SA (https=) |
| TW (2) | TW202444405A (https=) |
| UA (1) | UA129084C2 (https=) |
| WO (1) | WO2019183577A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020009950A (es) * | 2018-03-23 | 2021-04-28 | Carmot Therapeutics Inc | Moduladores de receptores acoplados a proteina g. |
| JP7688891B2 (ja) * | 2021-01-18 | 2025-06-05 | 国立大学法人東海国立大学機構 | ペプチド |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| US12281149B2 (en) | 2021-05-13 | 2025-04-22 | Carmot Therapeutics, Inc. | Modulators of G-protein coupled receptors |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| WO2024033374A1 (en) | 2022-08-11 | 2024-02-15 | Syngenta Crop Protection Ag | Novel arylcarboxamide or arylthioamide compounds |
| WO2024089216A1 (en) | 2022-10-27 | 2024-05-02 | Syngenta Crop Protection Ag | Novel sulfur-containing heteroaryl carboxamide compounds |
| WO2024096358A1 (ko) | 2022-11-04 | 2024-05-10 | 주식회사 엘지화학 | 홀로그램 기록 매체 및 이를 포함하는 광학 소자 |
| KR20240064272A (ko) * | 2022-11-04 | 2024-05-13 | 주식회사 엘지화학 | 불소계 화합물, 광중합성 조성물, 홀로그램 기록 매체, 이의 제조 방법 및 이를 포함하는 광학 소자 |
| JP2026500298A (ja) | 2022-12-15 | 2026-01-06 | シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト | 殺有害生物剤として有用である新規な二環式カルボキサミド化合物 |
| EP4698551A1 (en) * | 2023-04-21 | 2026-02-25 | The University of Hong Kong | Novel small molecule agonists of insulin receptor (insr) as anti-diabetes drugs |
| IL325257A (en) * | 2023-06-22 | 2026-02-01 | Carmot Therapeutics Inc | Synthesis of GLP-1R/GIPR agonists and their starting materials |
| CN120981457A (zh) | 2023-09-14 | 2025-11-18 | 歌礼制药(中国)有限公司 | Glp-1r激动剂及其治疗方法 |
| TW202521534A (zh) | 2023-11-24 | 2025-06-01 | 香港商歌禮製藥(中國)有限公司 | Glp-1r 激動劑及其治療方法 |
| US20260035406A1 (en) * | 2024-07-31 | 2026-02-05 | Carmot Therapeutics Inc. | Synthesis of glp-1r/gipr agonists |
| WO2026073030A1 (en) | 2024-09-27 | 2026-04-02 | Carmot Therapeutics Inc. | Combination therapy of peptide tyrosine-tyrosine (pyy) analogues and glp-1r agonists |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1072649C (zh) | 1995-09-13 | 2001-10-10 | 武田药品工业株式会社 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
| US6432947B1 (en) | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
| JP2002506792A (ja) * | 1998-02-27 | 2002-03-05 | ノボ ノルディスク アクティーゼルスカブ | Ｎ末端修飾ｇｌｐ−１誘導体 |
| CZ295044B6 (cs) * | 1998-12-07 | 2005-05-18 | Societe De Conseils De Recherches Et D'application | Analogy GLP-1, mající kyselinu aminoizomáselnou na pozicích 8 a 35, jejich použití a farmaceutické prostředky je obsahující |
| CN1364167A (zh) | 1999-02-26 | 2002-08-14 | 阿瑞那制药公司 | G蛋白偶联受体6的小分子调节剂 |
| WO2001017568A2 (en) | 1999-09-07 | 2001-03-15 | Conjuchem, Inc. | Bioconjugation in vivo to pulmonary or blood components |
| CA2416384A1 (en) | 2000-07-17 | 2003-01-16 | Takeda Chemical Industries, Ltd. | Sulfone derivatives, their production and use |
| AU2003278600A1 (en) | 2002-11-01 | 2004-05-25 | Takeda Pharmaceutical Company Limited | Agent for preventing or treating neuropathy |
| CA2505322A1 (en) | 2002-11-08 | 2004-05-21 | Takeda Pharmaceutical Company Limited | Receptor function regulator |
| US20070004736A1 (en) | 2002-11-22 | 2007-01-04 | Keiji Kubo | Imidazole derivative, process for producing the same, and use |
| WO2004067548A2 (en) * | 2003-01-31 | 2004-08-12 | Theratechnologies Inc. | Chemically modified metabolites of regulatory peptides and methods of producing and using same |
| EP1630152A4 (en) | 2003-05-30 | 2009-09-23 | Takeda Pharmaceutical | CONDENSED CYCLIC COMPOUND |
| BR122019021416A2 (https=) | 2003-09-19 | 2019-12-21 | ||
| EP1669352A4 (en) | 2003-09-30 | 2008-12-17 | Takeda Pharmaceutical | THIAZOLINE DERIVATIVE AND ITS USE |
| EP1695961A4 (en) | 2003-12-17 | 2007-10-24 | Takeda Pharmaceutical | UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE |
| AU2004309271A1 (en) | 2003-12-25 | 2005-07-14 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| WO2005063725A1 (ja) | 2003-12-26 | 2005-07-14 | Takeda Pharmaceutical Company Limited | フェニルプロパン酸誘導体 |
| JP4875978B2 (ja) | 2004-03-15 | 2012-02-15 | 武田薬品工業株式会社 | アミノフェニルプロパン酸誘導体 |
| US7517910B2 (en) | 2004-03-30 | 2009-04-14 | Takeda Pharmaceutical Company Limited | Alkoxyphenylpropanoic acid derivatives |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| US20060275288A1 (en) | 2005-01-20 | 2006-12-07 | Grihalde Nelson D | GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof |
| US8957070B2 (en) | 2005-04-20 | 2015-02-17 | Takeda Pharmaceutical Company Limited | Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity |
| CA2607566A1 (en) | 2005-05-06 | 2006-11-16 | Bayer Pharmaceuticals Corporation | Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use |
| US20090054435A1 (en) | 2005-07-29 | 2009-02-26 | Hiroshi Imoto | Phenoxyalkanoic Acid Compound |
| EP1916234B1 (en) | 2005-07-29 | 2014-11-12 | Takeda Pharmaceutical Company Limited | Cyclopropanecarboxylic acid compound |
| TW200740435A (en) | 2005-08-10 | 2007-11-01 | Takeda Pharmaceuticals Co | Therapeutic agent for diabetes |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| CN101420941A (zh) * | 2006-04-11 | 2009-04-29 | 艾尼纳制药公司 | Gpr119受体激动剂用于增加骨质量和用于治疗骨质疏松症的用途,和其相关组合疗法 |
| RS53230B (sr) | 2006-06-27 | 2014-08-29 | Takeda Pharmaceutical Company Limited | Kondenzovana ciklična jedinjenja kao modulatori gpr40 receptora |
| WO2008021560A2 (en) | 2006-08-17 | 2008-02-21 | Amylin Pharmaceuticals, Inc. | Dpp-iv resistant gip hybrid polypeptides with selectable properties |
| US8492405B2 (en) | 2006-10-18 | 2013-07-23 | Takeda Pharmaceutical Company Limited | Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity |
| RU2454415C9 (ru) | 2006-10-19 | 2013-02-27 | Такеда Фармасьютикал Компани Лимитед | Производное индола |
| EP2128138A1 (en) | 2007-01-29 | 2009-12-02 | Takeda Pharmaceutical Company Limited | Pyrazole compound |
| JP2010517935A (ja) | 2007-02-09 | 2010-05-27 | 武田薬品工業株式会社 | Ｐｐａｒ−ガンマのパーシャルアゴニストとしての縮合環化合物 |
| JPWO2008136428A1 (ja) | 2007-04-27 | 2010-07-29 | 武田薬品工業株式会社 | 含窒素５員複素環化合物 |
| WO2008156757A1 (en) | 2007-06-19 | 2008-12-24 | Takeda Pharmaceutical Company Limited | Indazole compounds for activating glucokinase |
| CN102105159B (zh) | 2008-06-17 | 2015-07-08 | 印第安纳大学研究及科技有限公司 | 基于gip的混合激动剂用于治疗代谢紊乱和肥胖症 |
| TW201006821A (en) * | 2008-07-16 | 2010-02-16 | Bristol Myers Squibb Co | Pyridone and pyridazone analogues as GPR119 modulators |
| US20120148586A1 (en) | 2009-08-27 | 2012-06-14 | Joyce Ching Tsu Chou | Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders |
| US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
| KR20120123443A (ko) | 2010-01-27 | 2012-11-08 | 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 | 대사 장애 및 비만 치료용 글루카곤 길항제-ｇｉｐ 항진제 콘쥬게이트 |
| US20120021979A1 (en) | 2010-06-24 | 2012-01-26 | Vanderbilt University | GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction |
| WO2013148579A1 (en) | 2012-03-29 | 2013-10-03 | Cebix Inc. | Pegylated c-peptide |
| AU2013341711A1 (en) * | 2012-11-12 | 2015-05-21 | Redwood Bioscience, Inc. | Compounds and methods for producing a conjugate |
| WO2014088432A1 (en) | 2012-12-06 | 2014-06-12 | Callaghan Innovation Research Limited | Conjugate compounds |
| US9766239B2 (en) | 2013-03-13 | 2017-09-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Synbodies for detection of human norovirus |
| EP3604271A1 (en) | 2013-06-28 | 2020-02-05 | Auckland Uniservices Limited | Peptides for amino acid and peptide conjugates and conjugation process |
| WO2015031268A1 (en) | 2013-08-26 | 2015-03-05 | Arizona Board Of Regents On Behalf Of Arizona State University | High affinity synbodies for influenza |
| EP3218414A1 (en) | 2014-11-14 | 2017-09-20 | Angiochem Inc. | Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin |
| WO2016131893A1 (en) | 2015-02-18 | 2016-08-25 | Medimmune Limited | Incretin fusion polypeptides |
| CN105219802A (zh) * | 2015-10-10 | 2016-01-06 | 广西大学 | 胰岛组织特异性表达GIPRdn慢病毒载体及其应用 |
| GB2551945B (en) | 2015-12-18 | 2021-09-08 | Heptares Therapeutics Ltd | Novel GLP-1 receptor agonist peptides |
| MX2020009950A (es) * | 2018-03-23 | 2021-04-28 | Carmot Therapeutics Inc | Moduladores de receptores acoplados a proteina g. |
-
2019
- 2019-03-22 MX MX2020009950A patent/MX2020009950A/es unknown
- 2019-03-22 IL IL311177A patent/IL311177B2/en unknown
- 2019-03-22 CA CA3094820A patent/CA3094820A1/en active Pending
- 2019-03-22 JP JP2021500508A patent/JP7526716B2/ja active Active
- 2019-03-22 AU AU2019237507A patent/AU2019237507B2/en active Active
- 2019-03-22 BR BR112020019148-5A patent/BR112020019148A2/pt unknown
- 2019-03-22 SG SG11202009338SA patent/SG11202009338SA/en unknown
- 2019-03-22 MY MYPI2020004952A patent/MY205468A/en unknown
- 2019-03-22 EP EP19772275.4A patent/EP3768294A4/en active Pending
- 2019-03-22 CN CN201980032743.8A patent/CN112236161A/zh active Pending
- 2019-03-22 US US17/040,653 patent/US11535660B1/en active Active
- 2019-03-22 IL IL277495A patent/IL277495B2/en unknown
- 2019-03-22 EA EA202092269A patent/EA202092269A1/ru unknown
- 2019-03-22 UA UAA202006366A patent/UA129084C2/uk unknown
- 2019-03-22 WO PCT/US2019/023726 patent/WO2019183577A1/en not_active Ceased
- 2019-03-25 TW TW113111309A patent/TW202444405A/zh unknown
- 2019-03-25 AR ARP190100749A patent/AR115016A1/es unknown
- 2019-03-25 TW TW108110353A patent/TWI840348B/zh active
-
2020
- 2020-09-23 PH PH12020551539A patent/PH12020551539A1/en unknown
- 2020-09-23 MX MX2025006799A patent/MX2025006799A/es unknown
-
2022
- 2022-12-22 US US18/087,063 patent/US20230357347A1/en not_active Abandoned
-
2024
- 2024-07-22 JP JP2024116690A patent/JP2024156720A/ja active Pending
-
2025
- 2025-04-16 AU AU2025202679A patent/AU2025202679A1/en active Pending
- 2025-09-09 IL IL323264A patent/IL323264A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531259A5 (https=) | ||
| Duffy et al. | The cannabinoid system and microglia in health and disease | |
| Salahuddin et al. | The role of amyloids in Alzheimer's and Parkinson's diseases | |
| Lazarov et al. | Neurogenesis and Alzheimer's disease: at the crossroads | |
| Najjar et al. | Neuroinflammation and white matter pathology in schizophrenia: systematic review | |
| Patel et al. | Targeting sonic hedgehog signaling in neurological disorders | |
| CY1107997T1 (el) | Νεες μεθοδοι που χρησιμοποιουν αναστολεις της χολινεστepασης | |
| JP2016023188A5 (https=) | ||
| CN106859588A (zh) | 试镜架 | |
| MX388726B (es) | Derivados de benzodiazepina, composiciones y métodos para tratar deterioro cognitivo. | |
| JP2019522044A5 (https=) | ||
| Wang et al. | Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer’s disease | |
| HRP20220029T1 (hr) | Supstituirani derivati ksantina | |
| JP2005502616A5 (https=) | ||
| CN106873187A (zh) | 试镜架 | |
| ECSP088477A (es) | Derivados de 3-alquilazetidina sustituidos con heterociclos | |
| Weiss et al. | Pathologies of calcium channels | |
| US10739616B2 (en) | Detachable spectacle frame | |
| WO2005097090A3 (en) | AGENTS THAT DISRUPT PSD95 - nNOS INTERACTION, COMPOSITIONS CONTAINING THE SAME, AND THERAPEUTIC USES THEREOF | |
| KR102312796B9 (ko) | 조향칼럼용 마운팅 브래킷의 제조를 위한 프로그레시브 금형 | |
| Lin et al. | Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer’s disease | |
| Nelson et al. | Phytocompounds as modulators of HSF1 in neurodegenerative disease: Special emphasis on Alzheimer's disease | |
| Jang et al. | Brain structural indicators of β-amyloid neuropathology | |
| EP3796905A4 (en) | ESTROGEN RECEPTOR BETA LIGANDS FOR THE PREVENTION AND TREATMENT OF MULTIPLE SCLEROSIS (MS) AND OTHER DEMYELINIZING, INFLAMMATORY AND NEURODEGENERATIVE DISEASES | |
| US3025761A (en) | Spectacle mountings |